摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Stryker's reagent

中文名称
——
中文别名
——
英文名称
Stryker's reagent
英文别名
[Ph3PCuH]6;[PPh3CuH]6;Stryker reagent;Stryker's complex;hydrido(triphenylphosphine)copper(I) hexamer;copper monohydride;triphenylphosphane
Stryker's reagent化学式
CAS
——
化学式
C108H96Cu6P6
mdl
——
分子量
1961.07
InChiKey
PYHLOCIDGQNZFY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    19.05
  • 重原子数:
    120
  • 可旋转键数:
    18
  • 环数:
    19.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

ADMET

代谢
主要通过胃肠道吸收,但也可以通过吸入和皮肤吸收。它通过基底外侧膜,可能是通过调节转运蛋白,并与血清白蛋白结合被运输到肝脏和肾脏。肝脏是稳态的关键器官。在肝脏和其他组织中,以与蛋白、氨基酸以及与依赖的酶结合的形式储存,然后分配通过胆汁排泄或并入细胞内和细胞外蛋白中。通过血浆中与血清白蛋白蓝蛋白或低分子量复合物结合的方式被运输到外周组织。可能诱导蛋白和蓝蛋白的产生。膜结合的转运腺苷三磷酸酶(Cu-ATPase)将离子输送到细胞内和细胞外。体内生理正常平的通过改变的吸收速率和数量、分布区域以及排泄来保持恒定。(L277, L279)
Copper is mainly absorbed through the gastrointestinal tract, but it can also be inhalated and absorbed dermally. It passes through the basolateral membrane, possibly via regulatory copper transporters, and is transported to the liver and kidney bound to serum albumin. The liver is the critical organ for copper homoeostasis. In the liver and other tissues, copper is stored bound to metallothionein, amino acids, and in association with copper-dependent enzymes, then partitioned for excretion through the bile or incorporation into intra- and extracellular proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. Copper may induce the production of metallothionein and ceruloplasmin. The membrane-bound copper transporting adenosine triphosphatase (Cu-ATPase) transports copper ions into and out of cells. Physiologically normal levels of copper in the body are held constant by alterations in the rate and amount of copper absorption, compartmental distribution, and excretion. (L277, L279)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 毒性总结
过量的被储存在肝细胞溶酶体中,在那里它与蛋白结合。当溶酶体饱和,在细胞核中积累,导致核损伤时,的肝脏毒性被认为会发生。这种损伤可能是由于氧化损伤,包括脂质过氧化。抑制含有巯基的酶,如葡萄糖-6-磷酸-1-脱氢酶、谷胱甘肽还原酶和对氧酶,这些酶保护细胞免受自由氧自由基的损害。它还影响基因表达,并且是氧化酶如细胞色素C氧化酶和赖氧化酶的辅因子。此外,由引起的氧化应激被认为会激活酸性鞘磷脂酶,导致神经酰胺的产生,这是一种凋亡信号,同时也会引起溶血性贫血。诱导的呕吐是由于迷走神经的刺激。
Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. Copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. This damage is possibly a result of oxidative damage, including lipid peroxidation. Copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. It also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. In addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. Copper-induced emesis results from stimulation of the vagus nerve. (L277, T49, A174, L280)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌物分类
对人类无致癌性(未列入国际癌症研究机构IARC清单)。
No indication of carcinogenicity to humans (not listed by IARC).
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 健康影响
人们每天必须吸收少量,因为对健康至关重要。然而,高平的可能有害。极高的剂量可能对肝脏和肾脏造成损害,甚至可能导致死亡。可能在敏感个体中引发过敏反应。
People must absorb small amounts of copper every day because copper is essential for good health, however, high levels of copper can be harmful. Very-high doses of copper can cause damage to your liver and kidneys, and can even cause death. Copper may induce allergic responses in sensitive individuals. (L278, L279)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 暴露途径
口服(L277);吸入(L277);皮肤给药(L277)
Oral (L277) ; inhalation (L277) ; dermal (L277)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 症状
吸入高浓度的可以导致鼻和喉咙的刺激。摄入高浓度的可以引起恶心、呕吐、腹泻、头痛、眩晕和呼吸困难。
Breathing high levels of copper can cause irritation of the nose and throat. Ingesting high levels of copper can cause nausea, vomiting, diarrhea, headache, dizziness, and respiratory difficulty. (L278, L279)
来源:Toxin and Toxin Target Database (T3DB)

反应信息

点击查看最新优质反应信息

文献信息

  • Copper-tungsten complexes with bridging tolylmethylidyne ligands: Crystal structure of the compound [CuW2(μ3-CC6H4Me-4)(CO)4(PPh3)(η-C5H5)2]·CH2Cl2
    作者:Mathias Müller-Gliemann、Simon V. Hoskins、A. Guy Orpen、Andrew L. Ratermann、F.Gordon A. Stone
    DOI:10.1016/s0277-5387(00)84439-3
    日期:1986.1
    [W(CC6H4Me-4)(CO)2(η-C5H5)] and [Cu(NCMe)4][PF6] in dichloromethane combine to form the salt [Cu&W(CC6H4Me-4)(CO)2(η-C5H5)&2][PF6], but the latter very readily dissociates in solution releasing the tolylmethylidynetungsten compound. The more stable salt [CuW(μ-CC6H4Me-4)(CO)2(NCMe)(PPh3) (η-C5H5)][PF6] is obtained by addition of [W(CC6H4Me-4)(CO)2(η-C5H5)] to a dichloromethane solution of [Cu(NCMe)4][PF6]
    摘要二氯甲烷中的络合物[W(CC6H4Me-4)(CO)2(η-C5H5)]和[Cu(NCMe)4] [PF6]结合形成盐[Cu&W(CC6H4Me-4)(CO) 2 [η- )&2] [PF6],但后者很容易在溶液中解离,释放出甲苯基甲基亚基化合物。通过添加[W(CC6H4Me-4)(CO)2( η- )]制成[Cu(NCMe)4] [PF6]的二氯甲烷溶液,该溶液预先用1 mol当量的PPh3处理。但是,在存在额外的PPh3的情况下,不会形成-络合物。研究了[CuW(μ-CC6H4Me-4)(CO)2(NCMe)(PPh3)(η- )] [PF6]的几种反应,但这些反应仅导致[W(CC6H4Me-4)的释放(CO)2(η-C5 H 5)]。化合物[&CuH(PPh3)&6]和[W(CC6H4Me-4)(CO)2(η- )]在甲苯中于室温反应,得
  • Mercaptothiacalixarenes Steer 24 Copper(I) Centers to form a Hollow‐Sphere Structure Featuring Cu <sub>2</sub> S <sub>2</sub> Motifs with Exceptionally Short Cu⋅⋅⋅Cu Distances
    作者:Nicolas Frank、André Dallmann、Beatrice Braun‐Cula、Christian Herwig、Christian Limberg
    DOI:10.1002/anie.201915882
    日期:2020.4.20
    stabilize the resulting [LCu4 ] units, which then remain monomeric ([(Ph3 PCu)4 L]). In the absence of donor ligands, they aggregate, providing a hexamer ([LCu4 ]6 ) in high yields, with a hollow-sphere structure formed by an unprecedented Cu24 S48 cage that is surrounded by the organic framework of the calixarene chalices. Preliminary NMR experiments with regard to the host-guest chemistry in solution showed
    四巯基四杂杯[4]芳烃(LH4)可以用作配位平台,在硫醇盐醚S原子上结合四个CuI离子。供体配体(例如膦)可以稳定生成的[LCu4]单元,然后保持单体状态([(Ph3 PCu)4 L])。在不存在供体配体的情况下,它们聚集在一起,以高收率提供六聚体([LCu4] 6),其空心球结构由空前的Cu24 S48笼子形成,并被杯芳烃圣杯的有机骨架所包围。关于溶液中主体-客体化学的初步NMR实验表明,该化合物代表乙腈甲烷的多官能主体。
  • Synthesis of mixed-metal clusters by the reaction of the unsaturated cluster [Os<sub>3</sub>(µ-H)<sub>2</sub>(CO)<sub>10</sub>] with transition-metal hydrides: the X-ray crystal structures of [Os<sub>3</sub>H<sub>3</sub>(CO)<sub>10</sub>{Cu(PPh<sub>3</sub>)}] and [Os<sub>3</sub>H<sub>3</sub>(CO)<sub>11</sub>{Ir(PPh<sub>3</sub>)}]
    作者:Brian F. G. Johnson、Jack Lewis、Paul R. Raithby、S. N. Azman、B. Syed-Mustaffa、Michael J. Taylor、Kenton H. Whitmire、William Clegg
    DOI:10.1039/dt9840002111
    日期:——
    dihydride cluster [Os3(µ-H)2(CO)10] reacts with the transition-metal hydrides [CuH(PPh3)}6], [IrH(CO)2(PPh3)2], [RhH(CO)(PPh3)2], and [NiH(Cl)(P(C6H11)3}2] to give the mixed-metal clusters [Os3H3(CO)10Cu(PPh3)}](1), [Os3H3(CO)11Ir(PPh3)}](2), [Os3H3(CO)11Rh(PPh3)}](3), and [Os3H2(CO)10Ni[P(C6H11)3]}](4). These complexes have been characterized by i.r. and n.m.r. spectroscopy, and the structures of (1)
    配位不饱和二氢化物簇[Os 3(µ-H)2(CO)10 ]与过渡氢化物[CuH(PPh 3)} 6 ],[IrH(CO)2(PPh 3)2 ],[RhH(CO)(PPh 3)2 ]和[NiH(Cl)(P(C 6 H 11)3 } 2)2给出混合属簇[Os 3 H 3(CO)10 Cu(PPh 3)}](1),[Os 3 H 3(CO)11 Ir(PPh 3)}](2),[Os 3 H 3(CO)11 Rh(PPh 3)}](3)和[Os 3 H 2(CO)10 Ni [P(C 6 H 11)3 ] }](4)。这些配合物已经通过红外光谱和核磁共振谱进行了表征,并且(1)和(2)的结构已经通过单晶X射线分析确定。在络合物(1)中,三个Os原子位于等腰三角形的顶点上,该等腰三角形的长边[3.026(3)Å]由Cu(PPh 3)配体氢化物没有直接定位,但是证据表明它们桥接了
  • Nelson, Gregory O., Organometallics, 1983, vol. 2, # 10, p. 1474 - 1475
    作者:Nelson, Gregory O.
    DOI:——
    日期:——
  • Lemmen; Goeden; Huffman, Inorganic Chemistry, 1990, vol. 29, # 19, p. 3680 - 3685
    作者:Lemmen、Goeden、Huffman、Geerts、Caulton
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫